Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions

被引:64
|
作者
Miller, Julie J. [1 ,2 ]
Castro, L. Nicolas Gonzalez [2 ,3 ,4 ]
McBrayer, Samuel [5 ]
Weller, Michael [6 ]
Cloughesy, Timothy [7 ]
Portnow, Jana [8 ]
Andronesi, Ovidiu [2 ,9 ]
Barnholtz-Sloan, Jill S. [10 ]
Baumert, Brigitta G. [11 ]
Berger, Mitchell S. [12 ]
Bi, Wenya Linda [2 ,13 ]
Bindra, Ranjit [14 ]
Cahill, Daniel P. [15 ]
Chang, Susan M. [12 ]
Costello, Joseph F. [12 ]
Horbinski, Craig [16 ,17 ,18 ]
Huang, Raymond Y. [2 ,19 ]
Jenkins, Robert B. [20 ]
Ligon, Keith L. [2 ,21 ]
Mellinghoff, Ingo K. [22 ]
Nabors, L. Burt [23 ]
Platten, Michael [24 ]
Reardon, David A. [2 ,3 ,4 ]
Shi, Diana D. [2 ,25 ]
Schiff, David [26 ]
Wick, Wolfgang [27 ,28 ]
Yan, Hai [29 ]
von Deimling, Andreas [30 ,31 ,32 ]
van den Bent, Martin [33 ]
Kaelin, William G. [2 ,34 ]
Wen, Patrick Y. [2 ,3 ,4 ]
机构
[1] Massachusetts Gen Hosp, Stephen E & Catherine Pappas Ctr Neurooncol, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Ctr Neurooncol, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA
[5] Univ Texas Southwestern Med Ctr Dallas, Childrens Med Ctr Res Inst, 6000 Harry Hines Blvd, Dallas, TX 75235 USA
[6] Univ Hosp Zurich, Dept Neurol, Frauenklinikstr 26, CH-8091 Zurich, Switzerland
[7] UCLA, Neurooncol Program, Los Angeles, CA USA
[8] City Hope Comprehens Canc Ctr, Oncol, Duarte, CA USA
[9] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA
[10] NCI, Informat & Data Sci IDS, Ctr Biomed Informat & Informat Technol CBIIT, Transdiv Res Program TDRP,Div Canc Epidemiol & Ge, Bethesda, MD 20892 USA
[11] Cantonal Hosp Graubunden, Inst Radiat Oncol, Chur, Switzerland
[12] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA
[13] Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA
[14] Yale Sch Med, Brain Tumor Ctr, Dept Therapeut Radiol, New Haven, CT USA
[15] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02115 USA
[16] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA
[17] Northwestern Univ, Feinberg Sch Med, Dept Neurol Surg, Chicago, IL 60611 USA
[18] Northwestern Univ, Northwestern Med Malnati Brain Tumor Inst Robert, Feinberg Sch Med, Chicago, IL 60611 USA
[19] Brigham & Womens Hosp, Dept Radiol, 75 Francis St, Boston, MA 02115 USA
[20] Mayo Clin, Dept Lab Med & Pathol, Individualized Med Res, Rochester, MN 55901 USA
[21] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA
[22] Mem Sloan Kettering Canc Ctr, Dept Neurol, Evnin Family Chair Neurooncol, 1275 York Ave, New York, NY 10021 USA
[23] Univ Alabama Birmingham, Dept Neurol, Heersink Sch Med, Birmingham, AL 35294 USA
[24] German Canc Res Ctr, CCU Neuroimmunol & Brain Tumor Immunol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany
[25] Brigham & Womens Hosp, Dept Radiat Oncol, 75 Francis St, Boston, MA 02115 USA
[26] Univ Virginia Hlth Syst, Dept Neurol, Div Neurooncol, Charlottesville, VA USA
[27] German Canc Res Ctr, Program Chair Neurooncol, Natl Ctr Tumor Dis NCT, Neurooncol, Heidelberg, Germany
[28] Neurol Clin Heidelberg, Heidelberg, Germany
[29] Genetron Hlth Inc, Gaithersburg, MD 20879 USA
[30] Univ Hosp Heidelberg, Dept Neuropathol, INF 224, D-69120 Heidelberg, Germany
[31] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, INF 224, D-69120 Heidelberg, Germany
[32] DKTK, INF 224, D-69120 Heidelberg, Germany
[33] Erasmus MC Canc Inst, Brain Tumour Ctr, Groene Hilledijk 301, NL-3075 EA Rotterdam, Netherlands
[34] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
关键词
D-2HG; glioma; Isocitrate dehydrogenase (IDH); LOW-GRADE GLIOMAS; CENTRAL-NERVOUS-SYSTEM; MAGNETIC-RESONANCE-SPECTROSCOPY; TERT PROMOTER MUTATIONS; RESPONSE ASSESSMENT; SURGICAL RESECTION; RADIATION-THERAPY; PHASE-III; ONCOMETABOLITE; 2-HYDROXYGLUTARATE; OLIGODENDROGLIAL TUMORS;
D O I
10.1093/neuonc/noac207
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Isocitrate dehydrogenase (IDH) mutant gliomas are the most common adult, malignant primary brain tumors diagnosed in patients younger than 50, constituting an important cause of morbidity and mortality. In recent years, there has been significant progress in understanding the molecular pathogenesis and biology of these tumors, sparking multiple efforts to improve their diagnosis and treatment. In this consensus review from the Society for Neuro-Oncology (SNO), the current diagnosis and management of IDH-mutant gliomas will be discussed. In addition, novel therapies, such as targeted molecular therapies and immunotherapies, will be reviewed. Current challenges and future directions for research will be discussed.
引用
收藏
页码:4 / 25
页数:22
相关论文
共 24 条
  • [1] Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
    Wen, Patrick Y.
    Weller, Michael
    Lee, Eudocia Quant
    Alexander, Brian M.
    Barnholtz-Sloan, Jill S.
    Barthel, Floris P.
    Batchelor, Tracy T.
    Bindra, Ranjit S.
    Chang, Susan M.
    Chiocca, E. Antonio
    Cloughesy, Timothy F.
    DeGroot, John F.
    Galanis, Evanthia
    Gilbert, Mark R.
    Hegi, Monika E.
    Horbinski, Craig
    Huang, Raymond Y.
    Lassman, Andrew B.
    Le Rhun, Emilie
    Lim, Michael
    Mehta, Minesh P.
    Mellinghoff, Ingo K.
    Minniti, Giuseppe
    Nathanson, David
    Platten, Michael
    Preusser, Matthias
    Roth, Patrick
    Sanson, Marc
    Schiff, David
    Short, Susan C.
    Taphoorn, Martin J. B.
    Tonn, Joerg-Christian
    Tsang, Jonathan
    Verhaak, Roel G. W.
    von Deimling, Andreas
    Wick, Wolfgang
    Zadeh, Gelareh
    Reardon, David A.
    Aldape, Kenneth D.
    van den Bent, Martin J.
    NEURO-ONCOLOGY, 2020, 22 (08) : 1073 - 1113
  • [2] Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
    Vargas Lopez, Antonio Jose
    NEURO-ONCOLOGY, 2021, 23 (03) : 502 - 503
  • [3] Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions
    Aizer, Ayal A.
    Lamba, Nayan
    Ahluwalia, Manmeet S.
    Aldape, Kenneth
    Boire, Adrienne
    Brastianos, Priscilla K.
    Brown, Paul D.
    Camidge, D. Ross
    Chiang, Veronica L.
    Davies, Michael A.
    Hu, Leland S.
    Huang, Raymond Y.
    Kaufmann, Timothy
    Kumthekar, Priya
    Lam, Keng
    Lee, Eudocia Q.
    Lin, Nancy U.
    Mehta, Minesh
    Parsons, Michael
    Reardon, David A.
    Sheehan, Jason
    Soffietti, Riccardo
    Tawbi, Hussein
    Weller, Michael
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2022, 24 (10) : 1613 - 1646
  • [4] Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensus
    Schiff, David
    Van den Bent, Martin
    Vogelbaum, Michael A.
    Wick, Wolfgang
    Miller, C. Ryan
    Taphoorn, Martin
    Pope, Whitney
    Brown, Paul D.
    Platten, Michael
    Jalali, Rakesh
    Armstrong, Terri
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2019, 21 (07) : 837 - 853
  • [5] Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions
    Wilcox, Jessica A.
    Chukwueke, Ugonma N.
    Ahn, Myung-Ju
    Aizer, Ayal A.
    Bale, Tejus A.
    Brandsma, Dieta
    Brastianos, Priscilla K.
    Chang, Susan
    Daras, Mariza
    Forsyth, Peter
    Garzia, Livia
    Glantz, Michael
    Oliva, Isabella C. Glitza
    Kumthekar, Priya
    Le Rhun, Emilie
    Nagpal, Seema
    O'Brien, Barbara
    Pentsova, Elena
    Lee, Eudocia Quant
    Remsik, Jan
    Ruda, Roberta
    Smalley, Inna
    Taylor, Michael D.
    Weller, Michael
    Wefel, Jeffrey
    Yang, Jonathan T.
    Young, Robert J.
    Wen, Patrick Y.
    Boire, Adrienne A.
    NEURO-ONCOLOGY, 2024,
  • [6] Neuro-oncology: Diagnosis and management of cerebral gliomas - Past, present, and future
    Gutin, PH
    Posner, JB
    NEUROSURGERY, 2000, 47 (01) : 1 - 8
  • [7] Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management
    Avila, Edward K.
    Tobochnik, Steven
    Inati, Sara K.
    Koekkoek, Johan A. F.
    Mckhann, Guy M.
    Riviello, James J.
    Ruda, Roberta
    Schiff, David
    Tatum, William O.
    Templer, Jessica W.
    Weller, Michael
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2024, 26 (01) : 7 - 24
  • [8] Indian Society of Neuro-Oncology consensus guidelines for the contemporary management of medulloblastoma
    Gupta, Tejpal
    Sarkar, Chitra
    Rajshekhar, Vedantam
    Chatterjee, Sandip
    Shirsat, Neelam
    Muzumdar, Dattatreya
    Pungavkar, Sona
    Chinnaswamy, Girish
    Jalali, Rakesh
    NEUROLOGY INDIA, 2017, 65 (02) : 315 - 332
  • [9] DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology
    Rahman, Rifaquat
    Shi, Diana D.
    Reitman, Zachary J.
    Hamerlik, Petra
    de Groot, John F.
    Haas-Kogan, Daphne A.
    D'Andrea, Alan D.
    Sulman, Erik P.
    Tanner, Kirk
    Agar, Nathalie Y. R.
    Sarkaria, Jann N.
    Tinkle, Christopher L.
    Bindra, Ranjit S.
    Mehta, Minesh P.
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2024, 26 (08) : 1367 - 1387
  • [10] The anticipated revision of the grading criteria for adult isocitrate dehydrogenase-mutant diffuse glioma within the neuro-oncology community
    Komori, Takashi
    NEURO-ONCOLOGY, 2019, 21 (12) : 1485 - 1486